[DOI] [PubMed] [Google Scholar] Ruf S, Rajagopal S, Kadnur SV, Hallur MS, Rani S, Kristam R, et al
For instance, in August 2025, Viking Therapeutics, a US-based company specializing in metabolic and endocrine disorder treatments, announced positive top-line results from its Phase 2 VENTURE-Oral Dosing trial of VK2735, an investigational oral dual GLP-1/GIP agonist for obesity
Front Environ Sci 2:39
0.33g of the crude Boc-His (Trt) -Aib-OSu and 1g of the compound 2 obtained in example 3 were dissolved in 20mL of N, N-dimethylformamide, 2mL of N, N-diisopropylethylamine was added, and the reaction was carried out at room temperature for 8 hours to obtain compound 4 with a purity of 74.08%, and a specific liquid phase diagram is shown in FIG
,
In general, the process would take 12 to 15 minutes